Central nervous system vasculitis

Journal of the Neurological Sciences

Volumn 153, Issue 2, 1998, Pages 159-171

  Fieschi, C ^a   Rasura, M ^a   Anzini, A ^a   Beccia, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Central nervous system; Vascular inflammatory diseases; Vasculitis

Indexed keywords

CYTOKINE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANGIOGRAPHY; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; DISEASE CLASSIFICATION; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

EID: 0032495506     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00288-8     Document Type: Article

References (76)

1. Berlit P., Moore P.M., Bluestein H.G. Vasculitis, rheumatic disease and the neurologist: the pathophysiology and diagnosis of neurologic problems in systemic disease. Cerebrovasc. Dis. 3:1993;139-145.
2. Bogousslavsky J., Regli F. Ischemic stroke in adults younger than 30 years of age. Arch. Neurol. 44:1987;479-488.
3. Bloch D.A., Michel B.A., Hunder G.G.et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis - patients and methods. Arthritis Rheum. 33:1990;1068-1073.
4. Bluestein, H.G., 1992. The central nervous system in systemic lupus erythematosus. In: Lahita, R.G., (Ed.), Systemic lupus erythematosus. 2nd Ed. Churchill Livingstone, New York, pp. 639-655.
5. Bluestein H.G., Zvaifler N.J. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 57:1976;509-516.
6. Calabrese L.H. Vasculitis of the central nervous system. Rheum. Dis. Cl. North Am. 21:1995;1059-1075.
7. Carolei A., Marini C., Ferranti E.et al. A prospective study of cerebral ischemia in the young - analysis of pathogenic determinants. Stroke. 24:1993;362-367.
8. Carvalho D., Savage C.O.S. Cytokines, adhesion molecules, antiendothelial cell autoantibodies and vascular disease. Cardiovasc. Pathol. 5:1996;350-367.
9. Chajek T., Fainaru M. Behcet's disease. Report of 41 cases and a review of the literature. Medicine. 54:1975;179-196.
10. Chuang V. Radiation-induced vasculitis. Semin. Roent Genol. 24:1994;64-69.
11. Citron B.P., Halpern M., MeCarron M.et al. Necrotizing angiitis associated with drug abuse. N. Engl. J. Med. 283:1990;1003-1011.
12. Cohen-Tervaert J.W., Limburg P.C., Elema J.D.et al. Autoantibodies against myeloid lysosomal enzymes: A useful adjunct to classification of patients with biopsy-proven arteritis. Am. J. Med. 91:1991;59-65.
13. Cohen-Tervaert J.W., Kallenberg C. Neurological manifestations of systemic vasculitides. Rheum. Dis. Clin. North Am. 19:1993;913-940.
14. Cupps, T.R., 1992. Infections in vasculitis: Mechanisms considered. In: Leruy, E.C. (Ed.): Systemic Vasculitis: The Biologic Basis. Marcel Dekker, New York, p. 483.
15. Denburg J.A., Behmann S.A. Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 Kd reactivity. Ann. Rheum. Dis. 53:1994;304-308.
16. Duffy J., Lidsky M.D., Sharp J.T.et al. Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore). 55:1976;19-37.
17. Duna G., Calabrese L.H. Limitations in the diagnostic modalities in the diagnosis of primary angiitis of the central nervous system (PACNS). J. Rheumatol. 22:1995;662.
18. Esnault V.L.M., Testa A., Audrian M.et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int. 43:1993;1329-1332.
19. Ferro D., Saliola M., Quintarelli C.et al. Methods for detecting lupus anticoagulants and their relationship with thrombosis and miscarriage in patients affected by systemic lupus erythematosus. J. Clin. Path. 45:1992;332-338.
20. Fieschi C., Rasura M., Anzini A.et al. A diagnostic approach to ischemic stroke in young and middle-aged adults. Eur. J. Neurol. 3:1996;324-330.
21. Fries J.F., Hunder G.G., Bloch D.A.et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis - Summary. Arthritis Rheum. 33:1990;1135-1136.
22. Gilbert G.J. Herpes zoster ophthalmicus and delayed contralateral hemiparesis. Relationship of the syndrome to central nervous system granulomatous angiitis. JAMA. 229:1974;302-304.
23. Gray F., Lescs M.C., Koehane C.et al. Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J. Neuropathol. Exp. Neurol. 51:1992;177-185.
24. Greenan T.J., Grossman R.I., Goldberg H.I. Cerebral vasculitis: MR imaging and angiographic correlation. Radiology. 182:1992;65-72.
25. Greer J.M., Longley S., Edwards N.L.et al. Vasculitis associated with malignancy: experience with 13 patients and literature review. Medicine. 67:1988;220-230.
26. Griffith M.E., Coulthart A., Pusey C.D. T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin. Exp. Immunol. 103:1996;253-258.
27. Guillevin L., Lhote F., Leon A.et al. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges - a prospective trial of 33 patients. J. Rheumatol. 20:1993;289-298.
28. Hall S., Buchbinder R. Takayasu's arteritis. Rheum. Dis. Clin. North Am. 16:1990;411-422.
29. Hanley J.G., Hong C. Antibodies to brain integral membrane proteins in systemic lupus erithematosus. J. Immunol. Meth. 161:1993;107-118.
30. Hilt D.C., Buchholz D., Krumholz A.et al. Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis; diagnosis and management approaches. Ann. Neurol. 14:1983;543-553.
31. Hoffman G.S., Kerr J.S., Leavitt R.Y.et al. Wegener granulomatosis: an analysis of 158 patients. Ann. Intern. Med. 11:1992;488-498.
32. Horner F.A., Myers G.J., Stumpf D.A.et al. Malignant atrophic papulosis (Kohlmeier-Degos diseasae) in childhood. Neurology (NY). 26:1976;317.
33. Hunder G.G., Lie J.T., Goronzy J.J.et al. Pathogenesis of giant cell arteritis. Arthritis Rheum. 36:1993;757-761.
34. Jayne D.R.W., Esnault U.L.M., Lockwood C.M. ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J. Autoimmun. 6:1993;207-219.
35. Jayne D.R.W., Lockwood C.M. Pooled intravenous immunoglobulin in the management of systemic vasculitis. Adv. Exp. Med. Biol. 336:1993;469-472.
36. Jennette J.C., Falk R.J., Andrassy K.et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 37:1994;187-192.
37. Jones M.W., Kaufmann J.C.E. Vertebrobasilar artery insufficiency in rheumatoid atlantoaxial subluxation. J. Neurol. Neurosurg. Psychiatry. 39:1976;122-126.
38. Joshi V.V., Pawel B., Connor E.et al. Arteriopathy in children with aquired immune deficiency syndrome. Pediatr. Pathol. 7:1987;261-275.
39. Kaku D.A., Lowenstein D.H. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann. Intern. Med. 113:1990;821-827.
40. Kallenberg G.C.G.M., Mulder A.H.L., Cohen T.J.W. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am. J. Med. 93:1992;675.
41. Kieburtz K.D., Eskin T.A., Ketonen L., Truite M.J. Opportunistic cerebral vasculophathy and stroke in patients with acquired immunodeficiency syndrome. Arch. Neurol. 50:1993;430-432.
42. Kitagawa Y., Gotoh F., Koto A., Ohayasu H. Stroke in systemic lupus erithematosus. Stroke. 21:1990;1533-1539.
43. Leavit R.Y., Fauci A.S. Polyangiitis overlap syndrome. Classification and prospective clinical experience. Am. J. Med. 81:1986;79.
44. Levine S.R., Brey R.L., Sawaya K.L.et al. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann. Neurol. 38:1995;831-836.
45. Lockwood C.M., Thir S., Isaacs J.et al. Long-term remission of intractable systemic vasculitis withmonoclonal antibody therapy. Lancet. 341:1993;1620-1622.
46. Mathieson P.W., Lockwood C.M., Oliviera D.G.B. T and B cell responses to cytoplasmic antigens in systemic vasculitis. Clin. Immunol. Immunopathol. 63:1992;135-141.
47. Masi A.T., Hunder G., Lie J.T.et al. The American College of Rheumatology 1990 criteria for the classification of churg-Strauss syndrome. Arthritis Rheum. 33:1990;1094-1100.
48. Minota S., Winfield J.B. Identification of three major target molecules of IgM anti-lymphocyte autoantibodies in systemic lupus erithematosus. J. Immunol. 139:1987;3644-3651.
49. Misiani R., Bellavita P., Fenili D.et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N. Eng. J. Med. 330:1994;751-756.
50. Mizusawa H., Hirano A., Llena J.F., Shintaku M. Cerebrovascular lesion in acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 76:1988;451-457.
51. Monteiro M.L.R., Swanson R.A., Coppeto J.R. A microangiopathic syndrome of encephalopathy, hearing loss, and retinal arteriolar occlusions. Neurology. 35:1985;1113-1121.
52. Moore P.M. Diagnosis and management of isolated angiitis of the central nervous system. Neurology. 39:1989;167-173.
53. Moore P.M. Neurological manifestation of vasculitis: update on immunopathogenic mechanisms and clinical features. Ann. Neurol. 37(S1):1995;S131-S141.
54. O'Duffy J.D., Goldstein N.P. Neurologic involvement in seven patients with Behcet's disease. Am. J. Med. 61:1976;170-178.
55. Parisi J.E., Moore P.M. The role of biopsy in vasculitis of the central nervous system. Semin. Neurol. 14:1994;341.
56. Peters M., Gottschalk D., Boit R., Pohle H.D., Ruf B. Meningovascular neurosyphilis in human immunodeficiency virus infection as a differential diagnosis of focal CNS lesions: a clinicopathological study. J. Infect. 27:1993;57-62.
57. Porges A.J., Redecha P.B., Kimberly W.T.et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via FC gamma RIIa. J. Immunol. 153:1994;1271-1280.
58. Rasmussen N., Jayne D.R., Abramowitz D.et al. European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. Clin. Exp. Immunol. 101(suppl 1):1995;29-34.
59. Renie W.A., Murphy R.P., Anderson K.C. The evaluation of patients with Eale's disease. Retina. 3:1983;243-248.
60. Richter C., Schnabel A., Csernok E., De Groot K., Reinhold-Keller E., Gross W.L. Treatment of anti-neutrophil cytoplasmatic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin. Exp. Immunol. 101:1995;12-17.
61. Said G., Lacrois-Ciaudo C., Fujimura H. The peripheral neuropathy of necrotizing arteritis: a clinicopathplogic study. Ann. Neurol. 23:1988;461-465.
62. Savage C.O.S., Harper L., Adu D. Primary systemic vasculitis. Lancet. 349:1997;553-558.
63. Scott D.G.I., Bacon P.A., Tribe C.R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine. 60:1981;288-297.
64. Scott D.G.I., Watts R.A. Classification and epidemiology of systemic vasculitis. Br. J. Rheumatol. 33:1994;897-900.
65. Sharer L.R., Epstein L.G., Cho E.S.et al. Pathologic features of AIDS encephalopathy in children: evidence for LAV/ HTLV-III infection of brain. Hum. Pathol. 17:1986;274-284.
66. Stegeman C.A., Cohen T.J.W., Huitema M.G., Kallenberg C.G.M. Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin. Exp. Immunol. 91:1993;415-420.
67. Stegeman, C.A., Cohen, T.J.W., De Jong, P.E., Kallenberg, C.G.M., for the Dutch Co-Trimoxazole Wegener Study Group, 1996. Trimethoprim-sulfamethoxazole (Co-Trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N. Eng. J. Med. 335, 16-20.
68. Susac J.O., Hardman J.M., Selhorst J.B. Microangiopathy of the brain and retina. Neurology. 29:1979;313-316.
69. Swelick, R.A., Lawley, T.J., 1991. Small-vessel vasculitis and cutaneous vasculitis. In: Churg, A., Churg, J. (Eds.), Systemic vasculitides. Igaku-Schoin, New York, p. 193.
70. Talal N. Sjogren's syndrome: historical overview and clinical spectrum of disease. Rheum. Dis. Clin. North Am. 18:1992;507-515.
71. Trevor R.P., Sondheimer F.K., Fessel W.J., Wolpert S.M. Angiographic demonstration of major cerebral vessel occlusion in systemic lupus erithematosus. Neuroradiology. 4:1972;202-206.
72. Willkens R. Current concepts of giant cell arteritis and polymialgia rheumatica. Clin. Aspect Autoimmun. 2:1987;2-7.
73. Zax R.H., Hodge S.J., Callen J.P. Cutaneous leukocytoclastic vasculitis. Arch. Dermatol. 126:1990;69-72.
74. Zhang A.G., Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum. 36:1993;1341-1349.
75. Zhang L., Jayne D., Zhao M.H., Lockwood C.M., Oliviera D.B.G. Distribution of MHC class II alleles in primary systemic vasculitis. Kidney Int. 47:1995;294-298.
76. Zhao M.H., Jones S.J., Lockwood C.M. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin. Exp. Immunol. 99:1995;49-56.